Herstellerprofil
Accord Healthcare Inc.
Pharmaunternehmen1 erfasste Produkte
1
erfasste Produkte
35.777
Meldungen insgesamt
54
dokumentierte Rückrufe
68,0%
schwerwiegend insgesamt
Produkte
1 von 1 angezeigt
| Produkt | Zugelassen | Meldungen ↓ | Top-Signal | Rückrufe |
|---|---|---|---|---|
| 1995 | 35.777 | Knochenmetastasen | 54 |
Rückrufhistorie · 50 dokumentiert
| Datum | Klasse | Grund | Firma |
|---|---|---|---|
| 26. Jan. 2026 | II | Presence of Foreign substance - potential presence of metal particulate matter | F.H. INVESTMENTS, Inc. (dba Asteria Health) |
| 26. Jan. 2026 | II | Presence of Foreign substance - potential presence of metal particulate matter | F.H. INVESTMENTS, Inc. (dba Asteria Health) |
| 26. Jan. 2026 | II | Presence of Foreign substance - potential presence of metal particulate matter | F.H. INVESTMENTS, Inc. (dba Asteria Health) |
| 22. Dez. 2022 | II | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. | Pharmacy Innovations |
| 23. März 2022 | II | Lack of sterility assurance. | Drug Depot, Inc., dba APS Pharmacy |
| 23. März 2022 | II | Lack of sterility assurance. | Drug Depot, Inc., dba APS Pharmacy |
| 7. März 2022 | II | Lack of Assurance of Sterility | TMC Acquisition LLC dba Tailor Made Compounding |
| 7. März 2022 | II | Lack of Assurance of Sterility | TMC Acquisition LLC dba Tailor Made Compounding |
| 7. März 2022 | II | Lack of Assurance of Sterility | TMC Acquisition LLC dba Tailor Made Compounding |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12. Okt. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 2. Juli 2020 | II | Lack of Processing Controls (lack of assurance of conformity to specifications). | MasterPharm LLC |
| 9. Mai 2019 | II | GMP Deviations: Potential cross contamination due to cleaning procedure failure. | American Health Packaging |
| 9. Mai 2019 | II | GMP Deviations: Potential cross contamination due to cleaning procedure failure. | American Health Packaging |
| 6. Mai 2019 | II | CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. | Zydus Pharmaceuticals USA Inc |
| 6. Mai 2019 | II | CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. | Zydus Pharmaceuticals USA Inc |
| 17. Okt. 2018 | II | Lack of Assurance of Sterility | Qualgen, LLC |
| 22. März 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22. März 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22. März 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22. März 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22. März 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22. März 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 9. Feb. 2018 | II | CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system. | American Pharmaceutical Ingredients LLC |
| 16. Nov. 2017 | II | Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product. | KRS Global Biotechnology, Inc |
| 16. Nov. 2017 | II | Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product. | KRS Global Biotechnology, Inc |
| 21. Sept. 2016 | II | Lack of Assurance of Sterility | Wells Pharmacy Network LLC |
| 19. Sept. 2016 | II | Superpotent and Subpotent drugs | Wells Pharmacy Network, LLC |
Klasse I = begründete Wahrscheinlichkeit schwerwiegender Schäden · Klasse II = vorübergehend oder reversibel · Klasse III = Schaden unwahrscheinlich.
Registrierungsstatus
Einige Produkte von Accord Healthcare Inc. sind nicht für die Anwendung am Menschen FDA-registriert. Für nicht registrierte Substanzen (Peptide, SARMs ohne Humanzulassung) existiert kein legitimer Anbieter für die Anwendung am Menschen. Das Fehlen eines Bezugswegs ist die Sicherheitsinformation.